Investor patience tested as pharmaceutical stocks take a tumble
Key Points The Health Care Select Sector SPDR Fund has dropped 3.81% in the last month and 8.03% in the past three months. Pharmaceuticals’ weak earnings reports are contributing to the healthcare sector’s recent underperformance. Bristol Myers Squibb, AbbVie, Merck, Johnson & Johnson, and Pfizer all traded below previous highs due to earnings concerns. 5 … Read more
